CBD for cancer: What does the science say?

CBD for cancer: What does the science say?

Cancer is a chronic disease that develops as a result of uncontrolled cell division in the body. Despite advances in scientific research, a universal cure for cancer has not yet been found. Among the most commonly used therapies are radiotherapy, chemotherapy and immunotherapy. Recently, there has been increasing interest in natural and gentle remedies that could improve the effectiveness of conventional therapies and reduce their side effects.

Phytocannabinoids, found in the hemp plant (Cannabis sativa), are some of the most interesting compounds to study in the context of cancer. One of the most well-known phytocannabinoids is cannabidiol (CBD), which has therapeutic properties without causing a psychotropic effect. In this article, we will look at what scientific research shows about the effect of CBD on various types of cancer.

Scientific evidence on the anti-cancer effects of CBD

Scientific research shows that CBD may have potential anti-cancer effects by inhibiting the spread of cancer cells and alleviating symptoms associated with cancer and its treatment:

1. Antitumor and antiproliferative properties: CBD has been shown to have the ability to stop the growth and spread of tumors. It can inhibit the migration of cancer cells and their adhesion to various organs and tissues.

2. Tumor angiogenesis: A study published in 2012 in the British Journal of Pharmacology shows that CBD may affect tumor angiogenesis – the process of forming new blood vessels that support tumor growth.

3. Symptom and side effect relief: CBD can help reduce anxiety, inflammation, and neuropathic pain that often accompany cancer or its treatment. These symptoms can significantly impair patients’ quality of life.

Research on various types of cancer

A number of studies have focused on the effects of CBD on various types of cancer, finding that it may be effective in reducing the viability of cancer cells:

1. Neuroblastoma, glioblastoma, melanoma, leukemia: Research shows that CBD can reduce the viability of cancer cells in these types of cancer, both in animal models and in vitro , making it a promising option for future clinical research.

2. Breast Cancer: A 2006 study found that CBD was one of the most potent inhibitors of breast tumor cell growth among five other cannabinoids tested, making it a potential candidate for further study and treatment of breast cancer.

3. Lung Metastasis: Studies have shown that CBD and extracts rich in this phytocannabinoid can prevent lung metastases. According to scientists, CBD may help kill cancer cells by activating TRPV-1 receptors and inducing oxidative stress.

4. Gene Regulation: A 2007 study found that CBD not only inhibited the proliferation of breast cancer cells, but also their spread. This is due to CBD’s ability to regulate the expression of key genes such as Id-1, which plays a role in cancer metastasis.

Safety and potential risks

While CBD has shown promise in laboratory settings, clinical studies are needed to confirm its effectiveness and safety in humans. It is important to note that CBD may interact with other medications and cause side effects such as nausea, fatigue, and changes in appetite. Patients considering using CBD as part of their treatment should consult a doctor.

Conclusion

CBD shows potential as an adjunct to conventional cancer therapies, with promising antitumorigenic and antiproliferative effects. However, clinical studies are needed to confirm these results and determine the best methods of administration and dosage. While further research is underway, it is important for patients to consult their doctors before starting CBD products.